Journal article 1027 views 823 downloads
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
Thinzar Min,
Steve Bain 
Diabetes Therapy, Volume: 12, Issue: 1, Pages: 143 - 157
Swansea University Authors:
Thinzar Min, Steve Bain
-
PDF | Version of Record
©The Author(s) 2020. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Download (379.28KB)
DOI (Published version): 10.1007/s13300-020-00981-0
Abstract
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
| Published in: | Diabetes Therapy |
|---|---|
| ISSN: | 1869-6953 1869-6961 |
| Published: |
Springer Science and Business Media LLC
2021
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa55784 |
| first_indexed |
2020-11-30T09:41:03Z |
|---|---|
| last_indexed |
2021-05-04T03:20:42Z |
| id |
cronfa55784 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2021-05-03T13:11:56.8429049</datestamp><bib-version>v2</bib-version><id>55784</id><entry>2020-11-30</entry><title>The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials</title><swanseaauthors><author><sid>27cba511a4800fefddb6885ffffdb8b2</sid><firstname>Thinzar</firstname><surname>Min</surname><name>Thinzar Min</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-11-30</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes Therapy</journal><volume>12</volume><journalNumber>1</journalNumber><paginationStart>143</paginationStart><paginationEnd>157</paginationEnd><publisher>Springer Science and Business Media LLC</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1869-6953</issnPrint><issnElectronic>1869-6961</issnElectronic><keywords>Glucagon-like peptide 1; Glucose-dependent insulinotropic polypeptide; Incretin hormone; Type 2 diabetes; Tirzepatide</keywords><publishedDay>1</publishedDay><publishedMonth>1</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-01-01</publishedDate><doi>10.1007/s13300-020-00981-0</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-05-03T13:11:56.8429049</lastEdited><Created>2020-11-30T09:38:47.0969735</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Thinzar</firstname><surname>Min</surname><order>1</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>2</order></author></authors><documents><document><filename>55784__19061__77d6641fb1ae4f2fbf05e99760d8d677.pdf</filename><originalFilename>55784.pdf</originalFilename><uploaded>2021-01-14T13:21:26.4032431</uploaded><type>Output</type><contentLength>388379</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>©The Author(s) 2020. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by-nc/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
| spelling |
2021-05-03T13:11:56.8429049 v2 55784 2020-11-30 The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials 27cba511a4800fefddb6885ffffdb8b2 Thinzar Min Thinzar Min true false 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2020-11-30 MEDS Journal Article Diabetes Therapy 12 1 143 157 Springer Science and Business Media LLC 1869-6953 1869-6961 Glucagon-like peptide 1; Glucose-dependent insulinotropic polypeptide; Incretin hormone; Type 2 diabetes; Tirzepatide 1 1 2021 2021-01-01 10.1007/s13300-020-00981-0 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2021-05-03T13:11:56.8429049 2020-11-30T09:38:47.0969735 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Thinzar Min 1 Steve Bain 0000-0001-8519-4964 2 55784__19061__77d6641fb1ae4f2fbf05e99760d8d677.pdf 55784.pdf 2021-01-14T13:21:26.4032431 Output 388379 application/pdf Version of Record true ©The Author(s) 2020. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License true eng http://creativecommons.org/licenses/by-nc/4.0/ |
| title |
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials |
| spellingShingle |
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials Thinzar Min Steve Bain |
| title_short |
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials |
| title_full |
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials |
| title_fullStr |
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials |
| title_full_unstemmed |
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials |
| title_sort |
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials |
| author_id_str_mv |
27cba511a4800fefddb6885ffffdb8b2 5399f4c6e6a70f3608a084ddb938511a |
| author_id_fullname_str_mv |
27cba511a4800fefddb6885ffffdb8b2_***_Thinzar Min 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain |
| author |
Thinzar Min Steve Bain |
| author2 |
Thinzar Min Steve Bain |
| format |
Journal article |
| container_title |
Diabetes Therapy |
| container_volume |
12 |
| container_issue |
1 |
| container_start_page |
143 |
| publishDate |
2021 |
| institution |
Swansea University |
| issn |
1869-6953 1869-6961 |
| doi_str_mv |
10.1007/s13300-020-00981-0 |
| publisher |
Springer Science and Business Media LLC |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
1 |
| active_str |
0 |
| published_date |
2021-01-01T14:02:08Z |
| _version_ |
1821323798098477056 |
| score |
11.048042 |